Clinical Trials Logo

Clinical Trial Summary

The goal of this post-marketing surveillance study is to compare two procedures which are used to treat patients who require a disc decompression procedure. These procedures are: 1) plasma disc decompression procedure using Coblation technology and 2) fluoroscopy guided transforaminal epidural steroid injection (TFESI). The study will evaluate treatment efficacy and rate of improvement in symptoms through the first six months following the procedure.

The principal objectives of this study are to determine whether subjects receiving the plasma disc decompression procedure demonstrate:

1. Improved clinical outcomes over subjects receiving TFESI

2. More rapid reversal of symptoms than subjects receiving TFESI


Clinical Trial Description

Chronic leg and back pain are two of the most common ailments in our society, and are associated with serious financial and social consequences. One surgical treatment modality is plasma disc decompression, based on the principle that inducing a small reduction of volume in the closed hydraulic space of an intact (contained herniated) disc can relieve pressure, and thereby reduce or eliminate pain. Another widely accepted treatment is transforaminal epidural steroid injection (TFESI), which delivers a high concentration of corticosteroid to the targeted disc nerve interface, and is thought to decrease pain by reducing inflammation.

This study proposes to compare the efficacy of the plasma disc decompression procedure to the standard TFESI series in patients who have failed to improve after an initial TFESI injection. The goal is to better understand the differences between these two treatment modalities and to monitor the rates of symptom improvement through the first six months between patients receiving a series of at least two selective nerve root injections and those undergoing the one-time plasma disc decompression procedure after failing one fluoroscopy guided TFESI. Patients will continue to be monitored over the 2-year post-procedure period to assess stability of treatment effect. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00189605
Study type Interventional
Source ArthroCare Corporation
Contact
Status Completed
Phase Phase 4
Start date September 2004
Completion date April 2009

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05487690 - Application of 3D Printing Guide Plate in Spinal Minimally Invasive and Interventional Surgeries N/A
Not yet recruiting NCT05632835 - Application of 3D Printing Guide Plate in Endoscopic Spinal Surgery N/A
Completed NCT01205464 - Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosis N/A
Not yet recruiting NCT05610553 - Application of 3D Printing Guide Plate in Percutaneous Disc Decompression N/A
Active, not recruiting NCT00880828 - Comparing Two Different Cervical Collars for the Treatment in Patient With Cervical Radiculopathy and Radicular Pain N/A
Recruiting NCT00516009 - Efficacy of Intravenous Dexamethasone for Acute Disc Herniation-Induced Sciatica N/A
Recruiting NCT05747807 - Percutaneous Intradiscal Radiofrequency as A Treatment for Radicular Pain From Lumbar Disc Herniation N/A